ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer

por Malek, Rohan, Wu, Sheng-Tang, Serrano, Dennis, Tho, Tran, Umbas, Rainy, Teoh, Jeremy, Lojanapiwat, Bannakji, Ong, Teng Aik, On, Weber Kam, Thai, Sam Minh, Kim, Janet, Pophale, Rupesh, Chiong, Edmund
Publicado 2022